King & Wood Mallesons advises on the structuring and close of Ysios BioFund II Innvierte
King & Wood Mallesons (KWM) advises Ysios Capital on the structuring and close of its second fund, Ysios BioFund II Innvierte, after receiving capital commitments of €126.4 M and exceeding its initial target fund size of €100 M. The strategy of this new fund is to invest in biotech start-ups and development phase companies.
Legal advice to Ysios Capital was led by Madrid Funds partner Isabel Rodríguez with the assistance of senior associate Ildefonso Alier.